The development of new strategies for enhancing drug delivery to the brain represents a major challenge in treating cerebral diseases. In this paper, we report on the synthesis and structural characterization of a biocompatible nanoparticle (NP) made up of poly(lactic-co-glycolic acid) (PLGA)-polyethylene glycol (PEG) co-polymer (namely PELGA) functionalized with the membranotropic peptide gH625 (gH) and the iron-mimicking peptide CRTIGPSVC (CRT) for transport across the blood-brain barrier (BBB). gH possesses a high translocation potency of the cell membrane. Conversely, CRT selectively recognizes the brain endothelium, which interacts with transferrin (Tf) and its receptor (TfR) through a non-canonical ligand-directed mechanism. We hypoth...
Many therapeutic drugs are excluded from entering the brain, due to their lack of transport through ...
Many therapeutic drugs are excluded from entering the brain, due to their lack of transport through ...
Targeted delivery of drugs across endothelial barriers remains a formidable challenge, especially in...
The development of new strategies for enhancing drug delivery to the brain represents a major challe...
The development of new strategies for enhancing drug delivery to the brain represents a major challe...
The development of new strategies for enhancing drug delivery to the brain represents a major challe...
Drug delivery to the Central Nervous System (CNS) represents a huge challenge for all neuroscientist...
Drug delivery to the Central Nervous System (CNS) represents a huge challenge for all neuroscientist...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded from entering the brain, due to their lack of transport through ...
Many therapeutic drugs are excluded from entering the brain, due to their lack of transport through ...
Targeted delivery of drugs across endothelial barriers remains a formidable challenge, especially in...
The development of new strategies for enhancing drug delivery to the brain represents a major challe...
The development of new strategies for enhancing drug delivery to the brain represents a major challe...
The development of new strategies for enhancing drug delivery to the brain represents a major challe...
Drug delivery to the Central Nervous System (CNS) represents a huge challenge for all neuroscientist...
Drug delivery to the Central Nervous System (CNS) represents a huge challenge for all neuroscientist...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded fromentering the brain due to their lack of transport through th...
Many therapeutic drugs are excluded from entering the brain, due to their lack of transport through ...
Many therapeutic drugs are excluded from entering the brain, due to their lack of transport through ...
Targeted delivery of drugs across endothelial barriers remains a formidable challenge, especially in...